Scientists Voice Concerns over Russian COVID-19 Vaccine Study
Scientists Voice Concerns over Russian COVID-19 Vaccine Study
Almost 40 scientists have signed an open letter, citing odd patterns in the data and a lack of transparency after authors withheld the full data.
Scientists Voice Concerns over Russian COVID-19 Vaccine Study
Scientists Voice Concerns over Russian COVID-19 Vaccine Study

Almost 40 scientists have signed an open letter, citing odd patterns in the data and a lack of transparency after authors withheld the full data.

Almost 40 scientists have signed an open letter, citing odd patterns in the data and a lack of transparency after authors withheld the full data.

vaccine design
Infographic: Mix and Match
Infographic: Mix and Match
Ruth Williams | Jul 13, 2020
How llamas and superglue might lead to antiviral therapies
Jean Macnamara’s Multiple Causes, 1931
Jean Macnamara’s Multiple Causes, 1931
Catherine Offord | Jul 13, 2020
The medical scientist made important contributions to polio treatment and Australian environmental policy—despite substantial resistance.
FDA to Require 50 Percent Efficacy for COVID-19 Vaccines
FDA to Require 50 Percent Efficacy for COVID-19 Vaccines
Amanda Heidt | Jul 1, 2020
Vaccine experts divided on whether that level of protection is too low or too demanding.
Infographic: Vaccines on Film
Infographic: Vaccines on Film
Ruth Williams | Jun 1, 2020
How an experimental preparation technique could make vaccines easier to transport, store, and administer
Vaccines Without Vials, Fridges, or Needles
Vaccines Without Vials, Fridges, or Needles
Ruth Williams | Jun 1, 2020
A novel preparation technique could facilitate vaccine preservation, transportation, and administration.
SARS-CoV-2–Fighting T Cells Found in Recovered Patients
SARS-CoV-2–Fighting T Cells Found in Recovered Patients
Shawna Williams | May 15, 2020
While the finding doesn’t prove people become immune to the virus after infection, it is good news for vaccine development.
BARDA Director Departs Post Overseeing COVID-19 Vaccine Efforts
BARDA Director Departs Post Overseeing COVID-19 Vaccine Efforts
Jef Akst | Apr 22, 2020
Rick Bright will no longer head the Biomedical Advanced Research and Development Authority and will instead work at the National Institutes of Health on diagnostics for SARS-CoV-2 infection.
Updated Sept 16
COVID-19 Vaccine Frontrunners
COVID-19 Vaccine Frontrunners
Jef Akst | Apr 7, 2020
Stay up-to-date on the progress of dozens of vaccine candidates that are currently undergoing clinical testing.
US Selects Two COVID-19 Vaccine Candidates for Huge Investments
US Selects Two COVID-19 Vaccine Candidates for Huge Investments
Amy Schleunes | Apr 1, 2020
The government is assisting Johnson & Johnson and Moderna with expediting clinical testing while at the same time prepping for large-scale manufacturing.